Дата | Компания | Событие | Описание | Результат |
---|---|---|---|---|
Trevena | Phase 2b | TRV-130, Painkiller | Успех | |
Flexion Therapeutics | PHASE 2B | FX006, osteoarthritis | Неуспех | |
Akebia Therapeutics | Phase 2 | Vadadustat, Anemia related to chronic kidney disease | Успех | |
Tetraphase Pharmaceuticals | Phase 3 | Eravacycline, Complicated urinary tract infections | Неуспех | |
Sangamo Biosciences | PHASE 2 | SB-728-1401, HIV/AIDS | Успех | |
Raptor Pharmaceuticals | PHASE 2 | RP-103, fatty liver disease | Неуспех | |
GW Pharmaceuticals | PHASE 2 | GWP42003, Schizophrenia | Успех | |
Apricus Biosciences | PHASE 2A | RAYVA, secondary Raynaud's phenomenon | Успех | |
Aerie Pharmaceuticals | Phase 3 | Rhopressa, Glaucoma & ocular hypertension | Успех | |
Heat Biologics | PHASE 2 | HS-110, cell lung | Успех | |
TRACON Pharmaceuticals | PHASE 2 | TRC105, hepatocelluar carcinoma | Успех | |
ADMA Biologics | BLA FILING | RI-002, immune deficiency diseases | Успех | |
Heron Therapeutics | PHASE 2 | HTX-011, post-operative pain | Успех | |
Puma Biotechnology | PHASE 2 | PB272, breast cancer | Успех | |
Synthetic Biologics | PHASE 2 | SYN-004 (C-IBS) | Неуспех | |
Verastem | Phase 2 | VS-6063, Pleural mesothelioma | Неуспех | |
Amicus Therapeutics | NDA FILING | MIGALASTAT, Fabry disease | Неуспех | |
Spark Therapeutics | PHASE 3 | SPK-RPE65, inherited retinal dystrohies | Успех | |
Neurocrine Biosciences | PHASE 3 | VMAT2 NBI-98854 - KINECT 3, tardive dyskinesia | Успех | |
Radius Health | NDA FILING | ABALOPARATIDE-SC, osteoporosis | Успех |